Drugs / FibCLOT
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05780125 | Mar 2023 → Feb 2024 | coagulation protein disease, heart disorder, hemorrhagic disease | IRCCS Policlinico S. Donato | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FibCLOT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05780125 ↗ |